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Abstract 
The effects of 4-hydroxy-3-nitrophenylglyoxal (HNPG), on the binding of eosin-5-maleimide (EMA), and diethyl pyrocarbonate 
(DEPC) to the anion transport system in the human red blood cell membrane, have been investigated. HNPG is a reversibly binding, 
arginine-specific, anion transport competitive inhibitor, known to act on the anion binding site. The EMA reaction site is an external 
facing lysine residue (Lys-430) in the 17 kDa transmembrane segment. The DEPC reaction site is an intracellular histidine (His-819) in 
the 35 kDa fragment. The results show that inhibition of the transport system with EMA increases in presence of HNPG to about 2.3 
times. This finding suggests a positive cooperativity between the HNPG and EMA binding site and give evidence that the essential 
arginine is either nearby or allosterically linked to Lys-430. The inhibition of the cells with DEPC was nearly unchanged or slightly 
decreased in the presence of 10 mM HNPG. These results suggest that the intracellular His-residue which reacts with DEPC is not a part 
of the transport pathway. Our experiments with 4,4'-dinitrostilbene-2,2'-disulfonate (DNDS) have shown that its affinity to the transport 
system does not change after pre-treatment with phenylglyoxal (PG). We also found that the binding of [HC]phenylglyoxal (PG) to band 
3 reduces ignificantly in presence of chloride. This is another evidence for the direct involvement of arginine residues in substrate 
binding. 
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1. Introduction 
Studies on the interactions between two different ypes 
of anion transport inhibitors was one of the main results 
that led to the identification of band 3 (AE1) as the protein 
which is responsible for the exchange of anions in human 
red blood cell membranes [1]. Our further investigations 
have shown that the transport system can be inhibited by a 
large number of arginine-specific reagents [2-7]. We have 
also been able to show that the inhibition caused by the 
irreversibly acting reagent phenylglyoxal decreases signifi- 
cantly in the presence of the substrate anions chloride and 
sulfate. We also found that the loaded transporter is unable 
to react with PG [4]. Such results suggested the involve- 
ment of arginine residues in the binding of the substrate 
anions. These findings have been confirmed through the 
Abbreviations: PG, phenylglyoxal; HNPG, 4-hydroxy-3- 
nitrophenylglyoxal; EMA, eosin-5-maleimide; DEPC, diethyl pyrocar- 
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use of the reversible inhibitor 4-hydroxy-3-nitro- 
phenylglyoxal (HNPG). This agent is found to act as a 
competitive inhibitor for both the substrate anions, chloride 
and sulfate [8]. 
Using [14C]phenylglyoxal, it has been shown that com- 
plete inhibition of the transport system is accompanied by 
modification of about three arginine residues. Two thirds 
of the [14C]phenylglyoxal was found on the 17 kDa trans- 
membrane segment and one third on the other 35 kDa 
fragment [3,9]. These segments result after cleavage of 
band 3 with extracellular chymotrypsin followed by trypsin 
'cleavage' from the cytoplasmic side [10,11]. Through 
structural activity studies with different phenylglyoxal 
derivatives and investigations on the chemical nature of 
the essential arginine residues, we have been able to 
suggest he important role of 4 arginine residues out of the 
44 residues found in band 3, that may be involved in the 
anion transport process [6,12,13]. These arginines are Arg- 
490, -514, -518 on the 17 kDa and Arg-730 on the 35 kDa 
fragments [6,12]. In order to verify this hypothesis and to 
get more information about the localization of the essential 
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arginine residues in the peptide chain, we studied the 
interaction between the arginine specific and competitive 
inhibitor HNPG and two anion transport inhibitors with 
well localized binding sites. The first one is eosin-5- 
maleimide (EMA) and the second one is diethyl pyrocar- 
bonate (DEPC). Both of them inhibit the transport system 
in a noncompetitive fashion, and bind to different locations 
on the transmembrane s gments of band 3. 
EMA is known to react with Lys-430, an extracellular 
lysine residue on the 17 kDa fragment [14]. DEPC is a 
histidine oriented reagent known to react with an intra- 
cellular histidine on the 35 kDa fragment, most probably 
819 [15,16]. We also investigated the inactivation of the 
transport system with the well studied stilbene derivative, 
4,4'-dinitrostilbene-2,2'-disulfonate (DNDS), after modifi- 
cation of the cells with phenylglyoxal. Also the effect of 
chloride ions on [14C]phenylglyoxal binding to band 3 and 
its fragments has been investigated. 
2. Experimental procedures 
2.1. Materials 
Human RH + blood was obtained from the blood bank 
in Frankfurt am Main, and stored at 4°C in 
acid/citrate/dextrose buffer. The cells were used within 4 
days of storage. 4-Hydroxy-3-nitrophenylglyoxal (HNPG) 
was synthesized according to [8], eosin-5-maleimide was 
purchased from Molecular Probes, USA. Diethyl pyrocar- 
bonate (DEPC) was from Sigma and DNDS was obtained 
from Aldrich. Phenylglyoxal (pure) was obtained from 
Serva, [14C]phenylglyoxal (15.1 mCi/mmol) from Amer- 
sham. Hepes was obtained from Calbiochem and all other 
buffer substances were from Merck, Darmstadt. 
2.2. Methods 
All the experiments presented in this paper were done 
with resealed human red blood cell ghosts. Resealed ghosts 
were prepared essentially as in [ 1 ]. Red cells were hemol- 
ysed at 0°C at a cell: medium ratio of 1:20 in a medium 
containing 4 mM Mg 2 SO4 and 1.45 mM acetic acid. 5 min 
after hemolysis, sucrose, gluconate, citrate and Hepes were 
added from a concentrated stock solution, to obtain a final 
concentration of 200 mM sucrose, 27 mM gluconate, 25 
mM citrate and 5 mM Hepes in the hemolysate. After 
centrifugation the ghosts were resuspended and resealed in 
standard medium (SM) containing (mM): 200 sucrose, 27 
gluconate, 25 citrate, 5 Hepes and 1 Na2SO 4. In the 
experiments done in chloride medium, sucrose was partialy 
replaced by chloride ions at the concentration i dicated in 
the figures. 
The reaction of the resealed ghosts with EMA was done 
in the dark at pH 7.4 at the concentrations indicated in the 
figures. The incubation time was 45 min. The experiments 
with DEPC were done in SM pH 7.4 at 0°C. The concen- 
tration of DEPC is indicated in the figures. Flux measure- 
ments and calculations of the rate constants were done as 
described previously [1]. Calculation of the sulfate flux 
was done according to Schnell [17]. The kinetic data were 
fitted with a least-squares method by a non-linear egres- 
sion program. Transport is expressed as percent residual 
activity relative to a control value measured in the same 
medium and under the same conditions, but without the 
inhibitors. 
In the experiments where the interaction between the 
reversibly binding inhibitors (HNPG and DNDS) and the 
irreversibly binding inhibitors EMA, DEPC and PG have 
been studied, the resealed ghosts were first incubated with 
the reversibly acting inhibitor for l0 min followed by 
incubation with the irreversible inhibitor under the condi- 
tions described above for each inhibitor. 
The reversibly binding inhibitor was then removed by 
washing the cells twice with standard buffer (SM), contain- 
ing 0,5% albumin, followed by further washes in standard 
buffer (SM) at 0°C. Then the cells were subjected to flux 
measurements. Polyacrylamide gel electrophoresis in SDS 
was carried out according to Laemmli [18] or Sch~igger et 
al. [19]. The slab gels were 1.5 mm thick. Determination of
the [14C]phenylglyoxal r dioactivity in gel slices was done 
as described previously [3]. Protein concentrations were 
determined according to Peterson [20] (which is a modifi- 
cation of the method of Lowry et al. [21]). 
3. Results 
3.1. Interaction between the essential arginines and the 
binding site for eosin-5-maleimide 
As described in Section 2 the resealed ghosts were first 
incubated with the reversibly acting competitive inhibitor, 
HNPG, for 10 rain at a concentration of 5 or 10 mM. 
Eosin-5-maleimide (EMA) was then added from a stock 
solution to give a final concentration of either 10 or 25 
p,M. After an incubation time of 45 rain the cells were 
washed as described in Section 2 to remove HNPG and the 
unreacted EMA. The modified ghosts were then resus- 
pended in standard buffer and sulfate effiux was measured. 
Fig. 1 shows that under our experimental conditions the 
inhibition of the transport system with 10 /~M EMA was 
about 34 + 4% (column 1). This inhibition increases to 
71 _+ 8.6% in the presence of l0 mM HNPG (column 2). 
Also at a concentration of 25 /~M EMA. the inhibition of 
the transport system was 51 _+ 10% (column 3). This inhi- 
bition increased to about 84 _+ 1.3% in the presence of 10 
mM HNPG (column 4). 
In Fig. 2, one can see that chloride ions have no effect 
on the inhibition of sulfate exchange with EMA. This is in 
agreement with the earlier observations of Knauf et al. [22] 
who found that EMA is a non-competitive inhibitor of C1 
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Fig. 1. Interaction between the HNPG binding site and the binding site 
for EMA. The ordinate represents he residual activity as percentage of a 
control value without EMA. The first and the third columns represent the 
effects of either 10 or 25 /xM EMA on the sulfate flux. The second and 
fourth columns how the effect of HNPG when present in the incubation 
medium containing EMA. 
(3 el 
Z 
O -r 
Z E 
el o 
RA (%) ~ Z 
100 - + E 
el 
80-  uJ + 
r,3 Q o 
el el 
uJ =E uJ 
60- ¢= E o 
E ~ = E 
40-  ~ m 
20- ~ m 
0 I I i I I 
1 2 3 4 5 
Fig. 3. Effect of HNPG on the inactivation of sulfate equilibrium ex- 
35 ~_ change by DEPC. Ordinate: The rate constant of--SOg exchange in 
percent of a control value in the same medium as in the columns without 
inhibitor. Resealed ghosts were exposed to either 2.5 or 5.0 mM DEPC. 
Column l and 3 show the inactivation of the resealed ghosts with 2.5 and 
5 mM DEPC. Column 2 and 4 represent the inactivation in presence of 10 
mM HNPG. Column 5 represents he transport activity of control cells 
without DEPC after removing the reversibly binding inhibitor HNPG. 
flux and that the site of reaction of EMA, Lys-430, is not 
at the anion transport site. 
3.2. Interaction between the essential arginines and the 
histidine residue modified by DEPC 
In this type of experiment, shown in Fig. 3, we have 
tried to determine if the anion transport site, known to 
react with HNPG, is near, or overlaps sterically or allo- 
sterically with the histidine residue, known to interact with 
DEPC and suggested to be His-819 [15,16]. The results 
show that at a concentration of 10 mM HNPG (a concen- 
tration under which all the anion binding sites are com- 
pletely occupied by this reagent) the inactivation of the 
transport system with DEPC is not or very slightly (about 
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Fig. 2. Chloride ions do not interact with EMA binding site. The curves 
show the inactivation of the sulfate equilibrium exchange in resealed 
ghosts with EMA in standard medium (0) ,  and in medium containing 
100 mM CI (O). Ordinate: rate of 35SO42- efflux in percent of a control 
value in the same medium as in (0 )  and (O) but without he inhibitor. 
Abscissa: EMA concentration (/xM), temp. 37°C, pH 7.4, incubation 
time 45 min. 
10-15%) changed. The concentration of DEPC in these 
experiments was either 2.5 or 5 mM (Fig. 3). 
The results presented in the diagram are averages of at 
least six experiments. 
3.3. Effect of phenylglyoxalation f resealed ghosts on the 
inactivation of the transport system by DNDS 
Resealed ghosts were first modified with 1.2 mM PG at 
pH 7.4 for 10 min at 37°C (under these conditions the 
transport is inhibited to about 30%). The excess of the 
inhibitor was removed by washing. The modified ghosts 
were then subjected to different concentrations of DNDS 
and sulfate effiux was measured. A control was run with 
ghosts without pre-treatment with phenylglyoxal, using the 
same concentration of DNDS. The results are shown in 
Fig. 4. One can see that pre-treatment of the cells with 
phenylglyoxal has no effect on the inactivation of the 
transport system with DNDS. 
The value of the ID50, i.e. the concentration of DNDS 
at which the transport system is half-inhibited, is about the 
same in both pre-treated and untreated cells, which was 
about 1.0 /xM. 
3.4. Chloride ions prevent he binding of [14C]phenyl- 
glyoxal to band 3 
In these experiments, the effect of chloride ions on the 
labelling of band 3 with [14C]PG and its transmembrane 
fragments, 35 kDa and 17 kDa, has been investigated. 
These segments generate after extracellular chymotrypsin 
treatment of the resealed ghosts followed by treatment of 
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Fig. 4. Pretreatment of resealed ghosts with PG has no effect on the 
inactivation of sulfate flux by DNDS. The ordinate represents he rate of 
inhibition of sulfate equilibrium exchange in resealed ghosts, with DNDS, 
in untreated cells (O), and in resealed ghosts after pre-treatment with 1.2 
mM PG for 10 rain (0) .  Transport is expressed as percentage of the 
residual activity relative to a control value measured in the same medium 
with similar ghosts (either untreated or PG pretreated). Abscissa: DNDS 
concentration i  /~M. 
the white ghosts with a low concentration of trypsin. 
Incubation of the resealed ghosts with [I4C]phenylglyoxal 
was done either in presence or absence of 100 mM chlo- 
ride. The concentration of phenylglyoxal was either 2.5 
mM or 1.25 mM. After an incubation time of ca. 30 min, 
the ghosts were washed to remove the unreacted reagent 
(Section 2). The ghost suspension was subdivided into two 
portions, one was used for flux measurements and the 
other one for gel electrophoresis. The amount of 
[]4C]phenylglyoxal binding to band 3 was calculated as 
described previously [3]. 
In the presence of 100 mM chloride ions the inhibition 
caused by 2.5 mM was reduced from 70% (column 1) to 
10% (column 2) in comparison to a control value without 
inhibitor (Fig. 5). The effect of chloride ions on the 
capacity of band 3 to bind [14C]PG has been calculated as 
previously described. In the absence of chloride ions, Fig. 
5 (first column), the amount of []4C]PG/mol band 3 was 
found to be 5.5 (about 2-3 arginine residues, since the 
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Fig. 5. Effect of chloride ions on phenylglyoxalation f resealed ghosts. 
Resealed ghosts were exposed to 2.5 mM phenylglyoxal for 45 min. The 
first column indicates the effect of phenylglyoxal. The second column 
represents the protective effect of chloride ions. Ordinate: The rate 
constant of 35SO4 exchange in percent of a control value in the same 
medium as in the experiments without inhibitors. 
o in absence of Cl" 
cpm 
• in presence of CI" 
1200 
80O 
6OO 
40O 
200- 
0 5 1'0 1'5 2'0 2'5 30 3; 4? 4'5 50 
slice number 
Fig. 6. Distribution of I~C phenylglyoxal residues inthe proteins of red 
blood cell membrane, in absence of chloride ions (upper curve), in 
presence of 100 mM chloride ions (lower curve). 
stoichiometry of the binding of PG to arginine residues 
was found to be 2:1 [24]), the degree of inhibition of 
sulfate transport was about 70%. These results are in 
agreement with previous results [3], where we found that 
complete inhibition of the transport system is accompanied 
by the modification of about 2-3 arginine residues. In the 
presence of chloride ions (second column), the amount of 
[14C]PG/mol band 3 was reduced to about 2.3 mol (about 
one arginine residue). The protection of the transport sys- 
tem was about 60%. These results show that 60% protec- 
tion of the transport activity is accompanied by less label- 
ing to about one arginine residue. 
In Fig. 6 the upper curve represents the radioactivity 
profile of the transmembrane fragments, 35 kDa and the 17 
kDa, in the absence of chloride ions, the lower curve in the 
presence of chloride ions. One can see that in the presence 
of chloride, there is a great reduction of the labeling of 
both fragments (30% reduction in the case of the 35 kDa 
fragment and 35% in the case of the 17 kDa fragment). 
4. D iscuss ion  
4.1. The EMA binding site 
It is clear from Fig. 1 that EMA is a good inhibitor for 
sulfate transport and its inactivation on the system is found 
to be concentration-dependent. Fig. 2 shows that chloride 
ions have no effect on the inhibition caused by EMA. 
These results confirm the results of Knauf et al. [22] who 
found that EMA does not act on the anion binding site. On 
the other hand, we found that the inhibition of the transport 
system with EMA increases in the presence of the compet- 
itive inhibitor HNPG. These results show that the helix 
that contains the essential Arg, must be near Lys-430 or 
allosterically linked to it, and can be explained in the 
following way: When the arginine specific reagent HNPG 
binds to the transport site, translocation of the anion cannot 
occur and the transporter may be fixed in a conformational 
state in which the substrate binding site is in the outward 
facing state. In this case the inhibitory binding site for 
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EMA, which is found to be on the extracellular site 
Lys-430 [14], may be near the transport channel (that may 
be composed of many adjacent helices) and more available 
when the transporter is fixed in the outward-facing confor- 
mation. In this case the inhibition caused by EMA in- 
creases. This is in agreement with Knauf and co-workers, 
who have shown that the EMA binding site does not 
overlap the transport site and suggested that EMA binds to 
a site that is affected by changes of the transport site 
conformation from the inward-facing to the outward-facing 
state and that EMA binds preferentially to the outward-fac- 
ing state [22]. Our results may demonstrate that HNPG 
binds to the transport site and prevents translocation of the 
anion and keeps the transporter in the outside-facing con- 
formation. 
4.2. DEPC binding site 
The results with DEPC are completely different. HNPG 
has little or nearly no effect on the inhibition caused by 
DEPC. This shows that there is no direct interaction 
between the transport site (HNPG site) and the histidine 
residue(s) which react(s) with DEPC. These results are 
similar to our previous results on the interaction between 
arginine-specific reagents and the stilbene disulfonate 
binding site, where we have been able to show, that after 
complete inhibition of the transport system with 2,3- 
butanedione, band-3 can still bind 3H2DIDS nearly up to 
its total capacity [7]. 
Our results with DNDS have shown that the affinity of 
DNDS to the transporter does not change after pre-treat- 
ment of the cells with PG. The DNDS concentration 
required to produce 50% inhibition of sulfate equilibrium 
exchange is the same in the unmodified and PG modified 
cells, which is about 1 /xM (this value is near the value 
(0.9 /xM) found by Barzilay and Cabantchik in 1979 [23]) 
This may confirm our previous results that PG either 
completely inhibits the transporter or not at all (all or 
non-behavior) and that the binding of PG to band 3 does 
not produce major conformational changes to the monomer 
molecule and its nearest neighbor. These results are con- 
trary to the findings of Wieth and his co-workers [25] who 
found that the affinity of DIDS decreases, or its binding is 
prevented after treatment of the cells with PG under their 
experimental conditions (at very high extracellular pH). 
They reported also that under such experimental conditions 
the reversible inhibition with phenylglyoxal is rather unin- 
fluenced by changes in the extracellular chloride concen- 
trations. They were also not able to show that the modifi- 
able residue can be recruited to the inside or the outside of 
the membrane barrier [26]. Under such experimental condi- 
tions phenylglyoxal may not bind to the anion binding site, 
but seems to bind to a site which interacts with the DIDS 
binding site and is not affected by the substrate anion 
chloride (for example - -  an extracellular lysine residue). 
The binding of [14C]phenylglyoxal to band 3 is reduced 
significantly in the presence of the substrate anion chloride 
(Fig. 6). This is another indication for the direct participa- 
tion of the arginine residues in the anion binding site. The 
reduction is found in both the 17 kDa and the 35 kDa 
fragment. These results are in agreement with our previous 
results [3] and support our hypothesis (Zaki [12,13]) that 
Arg-490, in the 17 kDa fragment and/or Arg-730 in the 
35 kDa fragment, may be present in the transport pathway. 
Site-directed mutagenesis of these residues are now being 
done and yields results which may support his hypothesis 
(Zaki and Passow and Karbach, et al., unpublished ata). 
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